Literature DB >> 33470189

Constitutive activation of mitogen-activated protein kinase kinase (MEK1) in ileal enterocytes leads to dysplasia and a predisposition to cancer.

Benjamin L Shneider1, Nahir Cortes-Santiago2, Deborah A Schady2, Swapna Krishnamoorthy1, Sundararajah Thevananther1, Kimal Rajapakshe3, Dimuthu Perera3, Shixia Huang3, Cristian Coarfa3,4.   

Abstract

Activation of mitogen-activated protein kinases (MAPKs) is a key factor in the pathogenesis of cancer, although the specific role of mitogen-activated protein kinase kinase (MEK1) is not well understood. Villin promoter-driven Cre expression was used to excise a floxed stop cassette from a phosphomimetically constitutively activated MEK1 (caMEK1) expression construct in the intestine of C57BL/6 mice. Zygosity status of caMEK1 afforded assessment of the dose dependence of the effect. The expected mendelian distribution of genotypes and sex was observed in 443 progenies. Between 21 and 63 days of life, caMEK1 had no effect on body weight in male mice, but reduced body weight in female mice homozygous for caMEK1. At 10 wk of age, the ileum of caMEK1-expressing mice was characterized by the finding of dysplasia and profound changes in overall architecture. Paneth cells were nearly absent in caMEK1 homozygotes. Targeted proteomic profiling via reverse phase protein array analyses with confirmatory Western blotting revealed significant changes in protein and phosphoprotein expression, including upregulation of proteins downstream of MEK1, associated with enhanced markers of proliferation, diminished apoptosis, alterations in cell-fate determination, cell-cell interactions, and tight junctions. Long-term viability of caMEK1 homozygous mice was reduced with no survival beyond 1 yr. Invasive adenocarcinoma developed in three of ten older mice [15 wk (homozygous), 26 wk (homozygous), and 35 wk (heterozygous) of age]. Expression of caMEK1 in enterocytes leads to marked derangements in the intestinal epithelium, which is associated with a predisposition to the development of invasive cancer.NEW & NOTEWORTHY The ileum of mice with constitutive expression of activated MEK1 (via phosphomimetic changes) in enterocytes is markedly abnormal with architectural distortion and cytologic atypia, which evolves into an adenoma invasive carcinoma sequence. Phosphoproteomic analysis reveals upregulation of proteins downstream of MEK1, associated with enhanced markers of proliferation, diminished apoptosis, alterations in cell-fate determination, cell-cell interactions, and tight junctions. This novel model provides new insights into intestinal homeostasis and carcinogenesis.

Entities:  

Keywords:  carcinogenesis; cell-fate; homeostasis; inflammation; intestine

Mesh:

Substances:

Year:  2021        PMID: 33470189      PMCID: PMC8202241          DOI: 10.1152/ajpgi.00065.2020

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  48 in total

1.  Signaling through ERK1/2 controls myelin thickness during myelin repair in the adult central nervous system.

Authors:  Sharyl L Fyffe-Maricich; Alexandra Schott; Molly Karl; Janet Krasno; Robert H Miller
Journal:  J Neurosci       Date:  2013-11-20       Impact factor: 6.167

2.  Caspase 7 downregulation as an immunohistochemical marker of colonic carcinoma.

Authors:  F Palmerini; E Devilard; A Jarry; F Birg; L Xerri
Journal:  Hum Pathol       Date:  2001-05       Impact factor: 3.466

3.  Absence of acute apoptotic response to genotoxic carcinogens in p53-deficient mice is associated with increased susceptibility to azoxymethane-induced colon tumours.

Authors:  Ying Hu; Richard K Le Leu; Graeme P Young
Journal:  Int J Cancer       Date:  2005-07-01       Impact factor: 7.396

4.  Shp2/MAPK signaling controls goblet/paneth cell fate decisions in the intestine.

Authors:  Julian Heuberger; Frauke Kosel; Jingjing Qi; Katja S Grossmann; Klaus Rajewsky; Walter Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

Review 5.  Targeting the RAF-MEK-ERK pathway in cancer therapy.

Authors:  Clara Montagut; Jeff Settleman
Journal:  Cancer Lett       Date:  2009-02-12       Impact factor: 8.679

Review 6.  Spatial and temporal signal processing and decision making by MAPK pathways.

Authors:  Oguzhan Atay; Jan M Skotheim
Journal:  J Cell Biol       Date:  2017-01-02       Impact factor: 10.539

7.  Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium.

Authors:  Raphael Brandt; Thomas Sell; Mareen Lüthen; Florian Uhlitz; Bertram Klinger; Pamela Riemer; Claudia Giesecke-Thiel; Silvia Schulze; Ismail Amr El-Shimy; Desiree Kunkel; Beatrix Fauler; Thorsten Mielke; Norbert Mages; Bernhard G Herrmann; Christine Sers; Nils Blüthgen; Markus Morkel
Journal:  Nat Commun       Date:  2019-07-02       Impact factor: 14.919

8.  Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium.

Authors:  Pauline Bastide; Charbel Darido; Julie Pannequin; Ralf Kist; Sylvie Robine; Christiane Marty-Double; Frédéric Bibeau; Gerd Scherer; Dominique Joubert; Frédéric Hollande; Philippe Blache; Philippe Jay
Journal:  J Cell Biol       Date:  2007-08-13       Impact factor: 10.539

9.  Mammary Stem Cells and Tumor-Initiating Cells Are More Resistant to Apoptosis and Exhibit Increased DNA Repair Activity in Response to DNA Damage.

Authors:  Chi-Hsuan Chang; Mei Zhang; Kimal Rajapakshe; Cristian Coarfa; Dean Edwards; Shixia Huang; Jeffrey M Rosen
Journal:  Stem Cell Reports       Date:  2015-08-20       Impact factor: 7.765

10.  Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation.

Authors:  Thomas Welte; Ik Sun Kim; Lin Tian; Xia Gao; Hai Wang; June Li; Xue B Holdman; Jason I Herschkowitz; Adam Pond; Guorui Xie; Sarah Kurley; Tuan Nguyen; Lan Liao; Lacey E Dobrolecki; Lan Pang; Qianxing Mo; Dean P Edwards; Shixia Huang; Li Xin; Jianming Xu; Yi Li; Michael T Lewis; Tian Wang; Thomas F Westbrook; Jeffrey M Rosen; Xiang H-F Zhang
Journal:  Nat Cell Biol       Date:  2016-05-16       Impact factor: 28.824

View more
  1 in total

Review 1.  Circular RNAs in hepatocellular carcinoma: Recent advances.

Authors:  Zhao-Shan Niu; Wen-Hong Wang
Journal:  World J Gastrointest Oncol       Date:  2022-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.